Castleark Management LLC Fibrogen Inc Transaction History

Castleark Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 12, 2019	SELL	$37.97 - $60.16 $2.85 Million - $4.52 Million	-75,185 Closed	0 $0
Q3 2018 Nov 15, 2018	BUY	$56.3 - $67.25 $4.23 Million - $5.06 Million	75,185 New	75,185 $4.57 Million
Q1 2018 May 15, 2018	SELL	$45.35 - $61.65 $4.94 Million - $6.72 Million	-109,025 Closed	0 $0
Q4 2017 Feb 15, 2018	SELL	$41.95 - $60.1 $4.08 Million - $5.85 Million	-97,275 Reduced 47.15%	109,025 $5.17 Million
Q3 2017 Nov 15, 2017	BUY	$33.4 - $53.9 $6.89 Million - $11.1 Million	206,300	206,300 $11.1 Million

37.4M

351K

105K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $30.9M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Castleark Management LLC, based on Form 13F filings with the SEC.

Stay updated on Castleark Management LLC with notifications on news.